Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-09

Clinical Trial Update: Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial validating the Leuven Postprandial Distress Scale (LPDS) in a placebo-controlled study for functional dyspepsia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Functional Dyspepsia | Phase 4 | Status: COMPLETED